Prof Michelle Lockley is a medical oncologist at University College London Hospitals (UCLH) in London, specialising in the treatment and clinical investigation of ovarian cancer. She completed a BSc and MBBS at University College London, gaining distinctions in medicine, anatomy, and obstetrics and gynaecology, before completing a PhD at the Barts Cancer Institute in 2008. She then held an NIHR Clinical Lectureship at the University of Cambridge and was appointed consultant in 2009, becoming Professor of Medical Oncology at Queen Mary University of London.
Why they are a top doctor
Research papers · PubMed
63
Published, peer-reviewed work, the clearest public measure of expertise in a specialty.
Cited by other doctors
4k
How often other doctors and researchers build on their work.
Background
Education
PhD, University of London (2004-2008)
MBBS (distinctions in medicine, anatomy, obstetrics and gynaecology), University College London (1991-1997)
BSc (1st class), University College London (1991-1994)
PhD, Barts Cancer Institute, 2008
NIHR Clinical Lectureship, University of Cambridge
Areas of focus
Gynaecological oncology Gynaecological Cancer (gynae-onc)
Memberships and affiliations
European Society of Gynaecological Oncology
British Gynaecological Cancer Society (BGCS)
Vice Chair, Malignant Germ Cell International Consortium (2022)
FRCP, Royal College of Physicians (2016)
Consultant in Medical Oncology, University College Hospital (2015)
Professor of Medical Oncology, Queen Mary University of London (2009)
Consultant in Medical Oncology, Barts Health NHS Trust (2009-2015)
Member, NCRI early onset working party
Vice Chair, Malignant Germ Cell Tumour International Consortium (MaGIC)
A surgeon who treats ovarian cancer and cervical cancer at University College Hospital. Treats ovarian cancer, cervical cancer, uterine cancer and vulvar cancer.